Business
Product Development and Commercial Update
Metir plc announced significant progress across its product portfolio, with Microtox® LX instrument production increasing and 19 systems sold year-to-date, alongside 144 customer quotations issued. A Memorandum of Understanding with MechLine-UK Ltd aims to introduce Microtox® technologies to major UK water companies. Commercial production of QuickChek® SRB kits is nearing restart, with over 20,500 kits quoted, representing potential revenues of £1.23 million. The company also reported successful real-world validation of its PFAS detection platform with ProDecon, with FIDCHEM set to use the data for AI development, and the Pathogen Detector Phase 2 is progressing. Disclaimer*
About this update from Metir Plc
4 August 2026 Metir plc ("Metir", the "Group" or the "Company") Product Development and Commercial Update Microtox® LX commercial momentum builds, MechLine-UK collaboration signed, QuickChek® SRB kit production restart and PFAS platform advances Metir plc (AIM: MET), the global provider of fast-response, mobile and point-of-use water and environmental monitoring technologies, is pleased to provide an update on commercial and product development progress across its product portfolio as the Company continues to execute its strategy of growing and building multiple recurring revenue streams. Highlights · Production of Microtox® LX instruments continues to increase, enabling supply from stock and trials with key new customers. · During 2026, 144 customer quotations were issued, including 83 quotations for Microtox® LX and FX instruments, with 19 Microtox® LX systems sold year-to-date. · Signed a Memorandum of Understanding with MechLine-UK Ltd to commence a plan to introduce Microtox® technologies across several UK water companies, including Thames Water, Affinity Water, Sutton & East Surrey Water and Portsmouth Water. · Significant progress towards restarting commercial production of QuickChek® SRB kits. · Customer quotations issued for more than 20,500 QuickChek® SRB kits representing potential sales revenues of approximately £1.23 million. · Successful real-world validation of Metir's proprietary PFAS detection platform with ProDecon. · FIDCHEM to commence using the PFAS analytical data to develop AI and machine-learning functionality. · Pathogen Detector Phase 2 to generate Cryptosporidium Optimer® progressing with Aptamer. Growing Microtox® commercial pipeline Production of Metir's market-leading Microtox® LX platform continues to increase, enabling the Company to sell units from stock and make units available for trials, with options to lease or purchase units. During 2026, the Company has issued 144 customer quotations, comprising 53 Microtox® instruments, 30 Microtox® FX instruments and 61 reagent and consumable quotations. To ...